Cite

HARVARD Citation

    Matsushita, K. et al. (2022). P2Y12 inhibition by clopidogrel increases adverse clinical events after transcatheter aortic valve replacement. International journal of cardiology. pp. 53-61. [Online]. 
  
Back to record